Avid Bioservices Inc (CDMO)

[geocappy1]

The pps was at $.40 several months back and the folks on this board realized based on data being given in Cc that the control group in the 2nd lung trial had an MOS of less than 6 months and the MOS for the treatment group was approaching 12 months by reading between the lines and continued buying. It turned out to be true and pps went to $5.40 before the third party error was discovered and the pps fell to $.70. It is now back to $1.28 and some hear believe they are going to salvage the 2nd line data. Those same people believe we may see a doubling of MOS in 1st line lung and pancreatic. The market didn't know before and they just may not know what is going on now. It wouldn't be the 1st time for a small biotech.
Of of risk and maybe a lot of reward. If you want low risk then buy bonds.